Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...
Get detailed forecast and price target charts for Pyxis Oncology, Inc. stock on Seeking Alpha. Click here to see the forecast for PYXS stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results